Epstein-Barr Virus latent membrane protein 1 overcomes all-trans retinoic acid-induced apoptosis by inhibiting retinoic acid receptor-β₂ expression

Riferimento: 
Biochem Biophys Res Commun. 2012 Jun 29;423(2):313-8.
Autori: 
Lee H, Seo SY, Tiwari I, Jang KL.
Fonte: 
Biochem Biophys Res Commun. 2012 Jun 29;423(2):313-8.
Anno: 
2012
Azione: 
L'oncoproteina Epstein-Barr Virus (EBV), latente proteina di membrana (LMP1), sopprime la morte cellulare per apoptosi provocata da acido all-trans retinoico (ATRA) nelle cellule del carcinoma nasofaringeo (NPC).
Target: 
EBV-ATRA/carcinoma nasofaringeo.

ABSTRACT
Nasopharyngeal carcinoma is closely associated with infection with Epstein-Barr Virus (EBV); however, the mechanism is still unclear. Here, we report that the EBV oncoprotein, latent membrane protein 1 (LMP1), suppresses apoptotic cell death provoked by all-trans retinoic acid (ATRA) in NPC cells. For this purpose, LMP1 downregulated levels of Bak whilst it upregulated levels of Bcl2, lowering the ratio of Bak to Bcl2. In addition, LMP1 suppressed ATRA-mediated activation of Caspase 9, Caspase 3, and PARP but not Caspase 8 in Ad-AH cells, suggesting that LMP1 acts by blocking the activation of intrinsic apoptosis pathway by ATRA. These effects were almost completely abolished when levels of retinoic acid receptor-β(2) (RAR-β(2)) in the LMP1-expressing cells were recovered by either exogenous gene expression or treatment with a universal DNMT inhibitor, 5-Aza-2'dC, indicating that LMP1 executes its antiapoptotic effects by downregulating levels of RAR-β(2) via DNA methylation.

Sostanze: